Metacrine, Inc(NASDAQ:MTCR) 
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with liver and gastrointestinal diseases. It is developing MET409 that has completed Phase 1b proof-of-concept clinical trial for the treatment of patients with non-alcoholic ste...
Website: http://www.metacrine.com
Founded: 2014
CEO: Preston S. Klassen
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2022-12-19
P
O 0.38
H 0.39
L 0.34
C 0.36
V 1,425,121
10EMA 0.36
20EMA 0.36
60EMA 0.36
120EMA 0.36
250EMA 0.36